Jorge Daniel Oldan1, Hae Won Shin2, Amir Hossein Khandani3, Carlos Zamora3, Thad Benefield3, Valerie Jewells3. 1. University of North Carolina-Chapel Hill, Department of Radiology, Chairman's Office 2006 Old Clinic, CB #7510 Chapel Hill, NC 27599, USA. Electronic address: jorge_oldan@med.unc.edu. 2. University of North Carolina-Chapel Hill, Department of Neurology, Physicians Office Building, 170 Manning Drive, CB #7025 Chapel Hill, NC 27599, USA. 3. University of North Carolina-Chapel Hill, Department of Radiology, Chairman's Office 2006 Old Clinic, CB #7510 Chapel Hill, NC 27599, USA.
Abstract
PURPOSE: Epilepsy surgery is the most successful method of treating medically unresponsive epilepsy, but carries a risk of morbidity. PET/MR is an emerging technique that increases detection of focal lesions whose resection may result in symptom remission. METHODS: Retrospective review of 74 focal epilepsy patients over a period of 3 years who had a PET/MR was performed following IRB permission and informed consent. 27 patients underwent surgery or RNS (responsive neurostimulator) placement. RESULTS: Hybrid PET-MR identified new anatomic or functional lesions in 10 patients not identified with standalone 3 T MR. Of the 27 patients who underwent focal surgery (19) or RNS placement (8), 24 showed improvement (Engel's I-III), 2 did not (Engel's IV), and one had an RNS explanted due to infection. MR and PET were read by 2 separate neuroradiologists and nuclear medicine physicians, respectively. Modalities were evaluated in terms of ability to detect the correct lobe and side for a focal lesion whose resection improved symptoms. Prior standalone MR exhibited 71-77% sensitivity and 0% specificity (as there were only 2 nonresponders), MR associated with PET/MR had 68-71% sensitivity and 0-50% specificity (depending on whether a lesion was seen on one of the nonresponders), and PET had 68-71% sensitivity and 25-33% specificity. Using either PET or MR to identify a focal lesion, PET/MR had sensitivity of 78-82% and specificity 0-50%. CONCLUSIONS: PET-MR provides additional sensitivity when used as two combined modalities for detecting possible epileptic foci.
PURPOSE:Epilepsy surgery is the most successful method of treating medically unresponsive epilepsy, but carries a risk of morbidity. PET/MR is an emerging technique that increases detection of focal lesions whose resection may result in symptom remission. METHODS: Retrospective review of 74 focal epilepsypatients over a period of 3 years who had a PET/MR was performed following IRB permission and informed consent. 27 patients underwent surgery or RNS (responsive neurostimulator) placement. RESULTS: Hybrid PET-MR identified new anatomic or functional lesions in 10 patients not identified with standalone 3 T MR. Of the 27 patients who underwent focal surgery (19) or RNS placement (8), 24 showed improvement (Engel's I-III), 2 did not (Engel's IV), and one had an RNS explanted due to infection. MR and PET were read by 2 separate neuroradiologists and nuclear medicine physicians, respectively. Modalities were evaluated in terms of ability to detect the correct lobe and side for a focal lesion whose resection improved symptoms. Prior standalone MR exhibited 71-77% sensitivity and 0% specificity (as there were only 2 nonresponders), MR associated with PET/MR had 68-71% sensitivity and 0-50% specificity (depending on whether a lesion was seen on one of the nonresponders), and PET had 68-71% sensitivity and 25-33% specificity. Using either PET or MR to identify a focal lesion, PET/MR had sensitivity of 78-82% and specificity 0-50%. CONCLUSIONS: PET-MR provides additional sensitivity when used as two combined modalities for detecting possible epileptic foci.
Authors: Sandra Saade-Lemus; Elad Nevo; Iman Soliman; Hansel J Otero; Ralph W Magee; Elizabeth T Drum; Lisa J States Journal: Pediatr Radiol Date: 2020-02-19
Authors: Kun Guo; Bixiao Cui; Kun Shang; Yaqin Hou; Xiaotong Fan; Hongwei Yang; Guoguang Zhao; Jie Lu Journal: Eur Radiol Date: 2021-02-27 Impact factor: 5.315
Authors: Katalin Borbély; Miklós Emri; István Kenessey; Márton Tóth; Júlia Singer; Péter Barsi; Zsolt Vajda; Endre Pál; Zoltán Tóth; Thomas Beyer; Tamás Dóczi; Gábor Bajzik; Dániel Fabó; József Janszky; Zsófia Jordán; Dániel Fajtai; Anna Kelemen; Vera Juhos; Max Wintermark; Ferenc Nagy; Mariann Moizs; Dávid Nagy; János Lückl; Imre Repa Journal: Biomedicines Date: 2022-04-20
Authors: Mariam Aboian; Ramon Barajas; Julia Shatalov; Vahid Ravanfar; Emma Bahroos; Elizabeth Tong; Jennie W Taylor; N Oberheim Bush; Patricia Sneed; Youngho Seo; Soonmee Cha; Miguel Hernandez-Pampaloni Journal: Neurooncol Pract Date: 2020-10-14